BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11481301)

  • 1. In vitro activity of cefditoren against clinical isolates of penicillin-susceptible and penicillin-intermediate strains of Streptococcus pneumoniae isolated in Germany, 1992-1998.
    Reinert RR; Al-Lahham A; Lütticken R
    J Antimicrob Chemother; 2001 Aug; 48(2):279-81. PubMed ID: 11481301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
    Yang Q; Xu Y; Chen M; Wang H; Sun H; Hu Y; Zhang R; Duan Q; Zhuo C; Cao B; Liu Y; Yu Y; Sun Z; Chu Y
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.
    Seral C; Suárez L; Rubio-Calvo C; Gómez-Lus R; Gimeno M; Coronel P; Durán E; Becerril R; Oca M; Castillo FJ
    Diagn Microbiol Infect Dis; 2008 Oct; 62(2):210-5. PubMed ID: 18715733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update of the activity of cefditoren and comparator oral beta-lactam agents tested against community-acquired Streptococcus pneumoniae isolates (USA, 2004-2006).
    Fritsche TR; Biedenbach DJ; Jones RN
    J Chemother; 2008 Apr; 20(2):170-4. PubMed ID: 18467241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of cefditoren against a special collection of clinical isolates of Streptococcus pneumoniae from Hungary.
    Nagy E; Marton A; Hajdú E
    Acta Microbiol Immunol Hung; 2003; 50(2-3):119-24. PubMed ID: 12894483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial activity of cefditoren against major community-acquired respiratory pathogens recently isolated in Italy.
    Stefani S; Mezzatesta ML; Fadda G; Mattina R; Palù G; Rossano F; Tufano MA; Schito GC; Nicoletti G
    J Chemother; 2008 Oct; 20(5):561-9. PubMed ID: 19028617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of penicillin/amoxicillin non-susceptibility on the activity of third-generation cephalosporins against Streptococcus pneumoniae.
    Fenoll A; Giménez MJ; Robledo O; Aguilar L; Tarragó D; Granizo JJ; Martín-Herrero JE
    Eur J Clin Microbiol Infect Dis; 2008 Jan; 27(1):75-80. PubMed ID: 17943330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antimicrobial activity of cefditoren and other oral antibiotics against Streptococcus pneumoniae, isolated from children with community acquired respiratory tract infections.
    Kang JH; Lee SY; Kim JH; Hur JK; Lee KY
    Jpn J Antibiot; 2010 Feb; 63(1):11-7. PubMed ID: 20836403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of cefditoren against respiratory pathogens.
    Clark CL; Nagai K; Dewasse BE; Pankuch GA; Ednie LM; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 2002 Jul; 50(1):33-41. PubMed ID: 12096004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of Streptococcus pneumoniae and Haemophilus influenzae to cefditoren, and provisional interpretive criteria.
    Fuchs PC; Barry AL; Brown SD
    Diagn Microbiol Infect Dis; 2000 Aug; 37(4):265-9. PubMed ID: 10974578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of oral cephalosporins against pediatric isolates of Streptococcus pneumoniae non-susceptible to penicillin, amoxicillin or erythromycin.
    Fenoll A; Giménez MJ; Robledo O; Aguilar L; Tarragó D; Granizo JJ; Gimeno M; Coronel P
    J Chemother; 2008 Apr; 20(2):175-9. PubMed ID: 18467242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility of recent clinical isolates of pneumococci to the investigational cephalosporin cefditoren.
    Karlowsky JA; Jones ME; Draghi DC; Critchley IA; Thornsberry C; Sahm DF
    Diagn Microbiol Infect Dis; 2002 Jan; 42(1):59-64. PubMed ID: 11821173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E test for studying in vitro activity of seven antimicrobial agents against penicillin-susceptible and penicillin-resistant pneumococci.
    Li J; Zhang Y; Chen Y; Hao F; Chen Y
    Chin Med J (Engl); 2000 Jul; 113(7):628-31. PubMed ID: 11776034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antimicrobial susceptibility and serotypes of Streptococcus pneumoniae isolated from the patients with respiratory tract infections in Hokusetsu Area of Osaka].
    Sugita K; Wakamiya E; Nishimura T; Oguni T; Yoshikawa K; Hijioka S; Kugo Y; Sugiki M; Uemura T; Inoue S
    Jpn J Antibiot; 2000 Jul; 53(7):512-21. PubMed ID: 11019385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-kill studies on susceptibility of nine penicillin-susceptible and -resistant pneumococci to cefditoren compared with nine other beta-lactams.
    Spangler SK; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 1997 Feb; 39(2):141-8. PubMed ID: 9069533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic susceptibility of respiratory pathogens recently isolated in Italy: focus on cefditoren.
    Tempera G; Furneri PM; Carlone NA; Cocuzza C; Rigoli R; Musumeci R; Pilloni AP; Prenna M; Tufano MA; Tullio V; Vitali LA; Nicoletti G
    J Chemother; 2010 Jun; 22(3):153-9. PubMed ID: 20566418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
    Gosbell IB; Fernandes LA; Fernandes CJ
    Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative activity of cefditoren and other oral beta-lactams against nonpneumococcal streptococci.
    Thornsberry C; Karlowsky JA; Kelly LJ; Draghi DC; Critchley IA; Jones ME; Sahm DF
    Chemotherapy; 2001; 47(5):332-43. PubMed ID: 11561135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media.
    Fenoll A; Aguilar L; Robledo O; Giménez MJ; Tarragó D; Granizo JJ; Gimeno M; Coronel P
    J Antimicrob Chemother; 2007 Aug; 60(2):323-7. PubMed ID: 17562681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.